Navigation Links
Prestigious Sloan Fellowship awarded
Date:2/23/2011

McGill University Neurologist Brian Chen has been awarded a prestigious Sloan Research Fellowship. Chen, a Canada Research Chair in Neural Circuit Formation, investigates a big subject: deciphering the assembly instructions for the brain.

His research focuses on how neural circuits wire up with precision. One of the central puzzles in neuroscience is how a neuron chooses the correct synaptic contacts during its development when faced with thousands of potential targets. To uncover the different molecules and strategies neurons use to self-assemble into a neural circuit, Chen's lab combines high-resolution imaging techniques with advanced molecular genetics in different model systems to investigate the common molecular rules used to wire up the brain.

Chen aims to provide an insight into how the brain's wiring diagram is encoded in the genome, and how this program can go awry in mental disorders and mental retardation. Thanks to the Sloan Fellowship award, he will be able to investigate how a gene within the Down Syndrome Critical Region, DSCAM, functions in the normal development of neural circuits and how it contributes to abnormal neural development in Down syndrome.

"We're very excited about Brian Chen's research into the development of neural circuits associated with Down Syndrome," said Richard Levin, Vice-Principal of Health Affairs and Dean of Medicine at McGill. "Nobody has looked at the way an excess of DSCAM may affect or impair neural development before. It's important work and we're more than proud that he has received this recognition and award."

Chen joins an illustrious group 38 Sloan Research Fellows have gone on to win Nobel Prizes. The Fellowships have been awarded annually since 1955 to "early-career scientists and scholars of outstanding promise" in recognition of the fact that financial assistance at this point in a researcher's career is often crucial to his or her future scientific success.

Of the total $5.9 million U.S. awarded annually, Chen will receive $50,000 over two years. The Fellowship is awarded by the Alfred P. Sloan Foundation, a philanthropic, not-for-profit institution based in New York City that makes grants to support original research and broad-based education related to science, technology, and economic performance.


'/>"/>

Contact: Katherine Gombay
katherine.gombay@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Related biology news :

1. HJF nursing specialist wins prestigious Celina Field Cargiver Award
2. Chemistry professor 1 of only 3 at UH to achieve prestigious AAAS status
3. High school students paper published in prestigious college math journal
4. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators
5. 2 McGill researchers garner prestigious NSERC Steacie Fellowships
6. Pest management specialist Charles Summers wins prestigious Woodworth Award
7. Springer Series editor John Smol receives two prestigious biology awards
8. Shaw to receive prestigious honor for plant pathology research
9. Academy Library accepted to prestigious Biodiversity Heritage Library
10. IGC scientist awarded prestigious European Research Council Starting grant
11. Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: